<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05083403</url>
  </required_header>
  <id_info>
    <org_study_id>2020-19</org_study_id>
    <nct_id>NCT05083403</nct_id>
  </id_info>
  <brief_title>HPI (Hypotension Prediction Index) Care Trial</brief_title>
  <official_title>A Randomized Trial of the Hypotension Prediction Index in the Cardiac Operating Room and the Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective single-center randomized controlled trial to determine if guided hemodynamic&#xD;
      management with the Acumen HPI technology in the OR and ICU can reduce the mean duration of&#xD;
      hypotension in cardiac surgery patients requiring cardiopulmonary bypass.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 30, 2021</start_date>
  <completion_date type="Anticipated">September 29, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment if the use of the AcumenTM HPI Feature Software reduces the mean duration of hypotension (defined as MAP &lt; 65mmHg)</measure>
    <time_frame>From post-bypass period to the first 8-hour ICU period</time_frame>
    <description>Assessment if the use of the AcumenTM HPI Feature Software reduces the mean duration of hypotension (defined as MAP &lt; 65mmHg)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Cardiopulmonary Bypass Surgery</condition>
  <arm_group>
    <arm_group_label>HPI Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AcumenTM HPI Software Feature to guide hemodynamic management in cardiac surgery post-CPB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-HPI Arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Non-protocolized standard of care management per clinician and provider judgement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcumenTM HPI Software Feature</intervention_name>
    <description>The AcumenTM HPI Feature Software provides the clinician with physiological insight into a patient's likelihood of trending toward a hypotensive event. The AcumenTM HPI Feature Software suite is enabled by the minimally invasive Acumen IQ sensor.</description>
    <arm_group_label>HPI Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-protocolized Standard of Care</intervention_name>
    <description>Non-protocolized standard of care to treat subjects</description>
    <arm_group_label>Non-HPI Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subjects who are at least 18 years of age&#xD;
&#xD;
          2. Subjects who have signed the Informed Consent Form&#xD;
&#xD;
          3. Subjects with planned pressure monitoring with an arterial line&#xD;
&#xD;
          4. Subjects with planned sternotomy&#xD;
&#xD;
          5. Subjects with planned general anesthesia&#xD;
&#xD;
          6. Subjects who have ASA Physical Status ≤ 4&#xD;
&#xD;
          7. Subjects with planned cerebral oximetry monitoring&#xD;
&#xD;
          8. Subjects with planned overnight hospitalization&#xD;
&#xD;
          9. Subjects with planned cardiopulmonary bypass (CPB) &quot;on-pump&quot; surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subjects with a physical site area too limited for proper Sensor placement&#xD;
&#xD;
          2. Subjects with contraindications for Arterial Line Placement;&#xD;
&#xD;
          3. Subjects participating in another (interventional) study&#xD;
&#xD;
          4. Subjects in whom an intraoperative MAP target will be &lt; 65 mmHg&#xD;
&#xD;
          5. Subjects with pre-op or pre-pump or post-pump LVEF ≤ 15%&#xD;
&#xD;
          6. Subjects requiring heart transplant&#xD;
&#xD;
          7. Subjects with pre-existing circulatory support devices or planned circulatory support&#xD;
             devices post-bypass&#xD;
&#xD;
          8. Subjects requiring emergency surgery&#xD;
&#xD;
          9. Subjects with known or identified severe PAH as determined by a pre-operative echo or&#xD;
             intraoperative Swan-Ganz&#xD;
&#xD;
         10. Subjects with cardiovascular instability in the operating room necessitating the need&#xD;
             to go back on bypass for a subsequent run&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kathy Akagha</last_name>
    <phone>(949)250-7169</phone>
    <email>Kathy_Akagha@edwards.com</email>
  </overall_contact>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 6, 2021</last_update_submitted>
  <last_update_submitted_qc>October 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cardiopulmonary bypass</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

